Jobs

CIDRAP seeks Deputy Director (full-time job)

Dear All, CIDRAP (Center for Infectious Diseases Research and Policy) at the University of Minnesota has posted a full-time job offering for a Deputy Director! Here’s my quick summary drawn both from the posted job description and a brief sidebar with CIDRAP staff: The job is very senior (part of CIDRAP’s Executive Team) and spans research

Read More »

Job Opportunity In Berlin With Global AMR R&D Hub!

Dear All, The Global AMR R&D Hub is looking for Head of the Global AMR R&D Hub Secretariat! The position would be based in Berlin and some of the position highlights are: Strategic vision and planning for the Hub, taking into consideration the global AMR R&D policy landscape Prepare recommendations on key R&D investment gaps and advocates

Read More »

ICARS seeks Executive Director

Dear All, An interesting job listing for you today! The International Centre for Antimicrobial Resistance Solutions (ICARS) is looking for an Executive Director. You can see more details on their vacancies page but here are some important details direct from ICARS — ICARS now seeks to appoint its first Executive Director to lead the organisation through its next

Read More »

Job openings with WHO and with ICARS (Copenhagen)

Dear All, What a wild day … it feels like the flood gates have opened! I am still smiling about the amazing BARDA announcement of 10 further years of funding for an Antibacterial Accelerator! In parallel, six (6!) contractor/job openings have popped onto my radar! Three are with WHO and three are with the recently created

Read More »

Major Job Opening: Head of the Global AMR R&D Hub Secretariat

Dear All, Launched in 2018, the Global AMR R&D Hub was established following a call from G20 Leaders to address challenges and improve coordination and collaboration in global AMR R&D using a One Health approach. For a bit more more context on the AMR R&D hub, see this 25 Aug 2020 newsletter about the hub’s dashboard project and

Read More »

WHO consultancy: Rollout of Policy Guidance on Integrated Stewardship Activities

Dear All, Just below my signature you will find the full details on a recently posted WHO consultancy opportunity. It’s an intriguing 6-month project during which you would be responsible for the rollout and implementation of a new WHO Policy Guidance on the Implementation of Integrated Antimicrobial Stewardship Activities. This guidance will be rolled out in

Read More »

Fabulous full-time AMR-focused leadership role at WHO! Apply now!

Dear All, Just now posted is an excellent opportunity to be a full-time Team Lead at WHO in the AMR group with Peter Beyer. Here’s the link you need: https://careers.who.int/careersection/ex/jobdetail.ftl?job=2100011 In brief, this is a very visible and senior Team Lead role with a top-level job description of “Develops and proposes innovative technical health policies

Read More »

Job with global impact: Director, CIDRAP Antimicrobial Stewardship Program

Dear All, Launched in 2016, the Antimicrobial Stewardship Program (ASP) at the Center for Infectious Disease Research and Policy (CIDRAP) of the University of Minnesota works to provide support globally to the the infectious disease community via such diverse activities as ASP-oriented podcasts, webinars, journal clubs, and other resources. CIDRAP itself is directed by the

Read More »

WHO seeks experts for critical antibiotics advisory group

Dear All, WHO have opened a call for experts to be part of an Advisory Group on their Critically Important Antimicrobial (CIA) List. Background: As discussed in this 12 Oct 2020 newsletter, WHO and FDA’s Center for Veterinary Medicine (CVM) rank antibiotics to determine which can be used in animals vs. those that must preserved for

Read More »

AMR Action Fund ($1b for P2-3) seeks Scientific Advisory Board

Dear All, I’ve previously written about the AMR Action Fund (9 Jul 2020 newsletter), a $1b fund created by 20+ global pharma with the intertwined goals of (i) bringing 2-4 new antibacterial antibiotics through Phase 2-3 and approval by 2030 and (ii) creating market conditions that enable sustainable investment in antibiotics. While we know that the

Read More »
Scroll to Top